Our curated suite of facilities incorporate the latest drug discovery capabilities to inspire and enable world-leading research for innovative therapeutics.
Our facilities are equipped with advanced tools and technologies to support each stage of the early drug discovery process. Facilities include DDI funded labs, University of Sydney’s core research facility for drug discovery, and externally managed facilities located on University grounds for ease of access and organic collaboration between our researchers.
The NSW Organoid Innovation Centre (NSWOIC) is a multi-institutional initiative to provide highly integrated capabilities for 3D organoid cultures, characterisation and pre-clinical drug development. Our facilities allow scaled-up production of organoids that are innovative and clinically relevant through to drug screening capabilities using cutting-edge bedside-to-bench strategy.
Through our centre, an unprecedented range of organoids are available to the academic and commercial sector to screen existing and novel molecules, as well as combinations in an organ-specific manner.
MedChem Australia is a national medicinal chemistry initiative which integrates our Centre’s expertise in collaboration with the Monash Institute of Pharmaceutical Sciences, WEHI and Therapeutics Innovation Australia to establish a framework for translating discoveries into optimised drug candidates.
Devised to address critical capability barriers, MedChem Australia provides medicinal chemistry and DMPK resources. Their far-reaching expertise bolsters innovative drug discovery through project support and engagement. MedChem Australia resources are available to successful applicants.
Funded by the DDI, the In Silico Drug Design Facility is situated in the University of Sydney, School of Pharmacy. The facility is equipped with top-of-the-line workstations for screening large libraries of compounds efficiently, and GPU-based workstation for rapid molecular dynamics experiments. Our expert user group who manages the facility can assist researchers in developing application grants and other submissions related to supercomputer methodology.
The Sydney Analytical Drug Discovery Node is the University of Sydney Core Research Facility for drug discovery. The facility is equipped with platforms for protein production and characterisation, cyclic peptide and fragment-based drug screening, 3D cell culture and a comprehensive range of advanced equipment.
